Literature DB >> 16260278

Clonal proliferation of cyclin D1-positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?

Blanca Espinet1, Francesc Solé, Carme Pedro, Mar Garcia, Beatriz Bellosillo, Marta Salido, Lourdes Florensa, Francisca I Camacho, Teresa Baró, Josep Lloreta, Sergi Serrano.   

Abstract

Mantle cell lymphoma (MCL) is a B-cell neoplasm with a relatively aggressive clinical course. There is a very small subgroup of patients who present with atypical lymphocytes in peripheral blood, with or without lymphocytosis, lymphadenopathy, or splenomegaly, and with an indolent clinical course. They frequently show mutated IgV(H) genes and CD5 negativity. We report an asymptomatic elderly patient who presented with a single submandibular lymphadenopathy. The biopsy showed immunophenotype and t(11;14)(q13;q32) consistent with MCL. The abnormal lymphoid population was also detected in peripheral blood and bone marrow. The patient has remained asymptomatic for 5 years without receiving any therapy. It is uncertain whether these cases represent an early-stage event in the development or an indolent form of MCL. The existence of such asymptomatic patients with an indolent clinical course should induce a strict clinical judgment in terms of therapeutic decisions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260278     DOI: 10.1016/j.humpath.2005.08.021

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Authors:  Falko Fend; José Cabecadas; Philippe Gaulard; Elaine S Jaffe; Philip Kluin; Isinsu Kuzu; Loann Peterson; Andrew Wotherspoon; Christer Sundström
Journal:  J Hematop       Date:  2012-09       Impact factor: 0.196

Review 2.  Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Authors:  Birgitta Sander; Leticia Quintanilla-Martinez; German Ott; Luc Xerri; Isinsu Kuzu; John K C Chan; Steven H Swerdlow; Elias Campo
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

3.  Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Authors:  Blanca Espinet; Ana Ferrer; Beatriz Bellosillo; Lara Nonell; Antonio Salar; Concepción Fernández-Rodríguez; Eulàlia Puigdecanet; Javier Gimeno; Mar Garcia-Garcia; Maria Carmen Vela; Elisa Luño; Rosa Collado; José Tomás Navarro; Esmeralda de la Banda; Pau Abrisqueta; Leonor Arenillas; Cristina Serrano; Josep Lloreta; Belén Miñana; Andrea Cerutti; Lourdes Florensa; Alberto Orfao; Ferran Sanz; Francesc Solé; David Dominguez-Sola; Sergio Serrano
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

4.  In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior.

Authors:  Alejandra Carvajal-Cuenca; Luz F Sua; Nhora M Silva; Stefania Pittaluga; Cristina Royo; Joo Y Song; Rachel L Sargent; Blanca Espinet; Fina Climent; Samuel A Jacobs; Jan Delabie; Kikkeri N Naresh; Adam Bagg; Pierre Brousset; Roger A Warnke; Sergi Serrano; Nancy Lee Harris; Steven H Swerdlow; Elaine S Jaffe; Elías Campo
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.

Authors:  Sarah L Ondrejka; Raymond Lai; Stephen D Smith; Eric D Hsi
Journal:  Haematologica       Date:  2011-04-20       Impact factor: 9.941

Review 6.  The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.

Authors:  Elias Campo; Steven H Swerdlow; Nancy L Harris; Stefano Pileri; Harald Stein; Elaine S Jaffe
Journal:  Blood       Date:  2011-02-07       Impact factor: 22.113

7.  Clinicopathologic features of CDK6 translocation-associated B-cell lymphoproliferative disorders.

Authors:  Dong Chen; Mark E Law; Jason D Theis; Jeffrey D Gamez; Lynn B Caron; Julie A Vrana; Ahmet Dogan
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

Review 8.  [In situ lymphoma and other early stage malignant non-Hodgkin lymphomas].

Authors:  L Quintanilla-Martínez; P Adam; F Fend
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

9.  Mantle cell lymphoma with partial involvement of the mantle zone: an early infiltration pattern of mantle cell lymphoma?

Authors:  Assia Bassarova; Anne Tierens; Grete Fossum Lauritzsen; Alexander Fosså; Jan Delabie
Journal:  Virchows Arch       Date:  2008-08-12       Impact factor: 4.064

Review 10.  Mantle cell lymphoma with in situ or mantle zone growth pattern: a study of five cases and review of literature.

Authors:  Peihong Hsu; Tianyu Yang; Silvat Sheikh-Fayyaz; Judith Brody; Jela Bandovic; Sarma Roy; Jordan Laser; Jonathan E Kolitz; Craig Devoe; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.